Real-World Data Show Tdap Vaccination During Pregnancy Reduces Infant Pertussis Risk
Tdap vaccination in the recommended 27–36-week window provides the largest benefit.
Pediatrics
Even Moderate Caffeine Intake in Pregnancy Tied to Smaller Babies
Consuming more than 50 mg of caffeine per day (the amount in about half a cup of coffee) linked to lower birth weight
FDA to Decide ‘Quickly’ on Pfizer Request to Approve COVID-19 Vaccine for Children 12 to 15
Currently, the FDA allows the Pfizer vaccine to be given to people 16 years and older
Diet, Exercise Intervention Explored in Children With B-ALL
Reduction in fat gain not seen in overall cohort, but stratified analysis showed benefit among those overweight, obese at baseline
MPR Weekly Dose Podcast 74
Back to regular programming this week with a summary of the top news, which includes updated travel guidance; Six month efficacy data for the Moderna and Pfizer-BioNTech vaccines; Vial doses increased for Moderna; A new ADHD drug is approved; And the FDA has issued a safety communication regarding lamotrigine.
Stethoscope Remains Best Way to Monitor Fetal Distress During Labor
Review of 33 studies, including seven monitoring methods, shows no benefit from newer strategies
Two Peaks in MIS-C Followed COVID-19 Peaks in the US
Lowest proportion of severe manifestations seen in patients aged 0 to 4 years, but 44.3 percent admitted for intensive care
Decline in Mean BP Among US Children, Teens Between 1999 to 2018
However, authors warn that stagnation and possible increase in more recent years may indicate reversal of trend
Pregnant Women Show Robust Immune Response to COVID-19 Vaccine
And passage of antibodies through the placenta and breastmilk appears to confer immunity to newborns
Qelbree, a Nonstimulant Treatment for ADHD, Gets FDA Approval
The approval was based on data from an extensive development program that included four phase 3 studies involving more than 1000 patients 6 to 17 years of age with ADHD.
